Callan Family Office »

Maxcyte shares owned by Callan Family Office

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Callan Family Office from 13F filings

Historical chart of Callan Family Office investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by Callan Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by Callan Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $85k 55k 1.55

More positions owned by Callan Family Office

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Vanguard Scottsdale Fds Vng Rus3000idx (VTHR)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Ishares Tr Rus 1000 Grw Etf (IWF)
Visa Com Cl A (V)

View all positions for Callan Family Office

Top funds holding Maxcyte

BlackRock
Cadian Capital Management
Mirabella Financial Services
Vanguard Group
Vitruvian Partners
Mudita Advisors
Bnp Paribas Investment Partners
AXA Investment Managers
Geode Capital Management
State Street Corporation
Jacobs Levy Equity Management
Dimensional Fund Advisors
Willis Investment Counsel
Citadel Advisors
Renaissance Technologies

View all funds holding Maxcyte